Passage Bio Inc. (PASG)
0.58
-0.02 (-2.85%)
At close: Jan 15, 2025, 1:54 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Net Income | -102.06M | -136.13M | -185.39M | -112.23M | -45.63M | -12.77M |
| Depreciation & Amortization | 3.72M | 3.68M | 1.54M | 800.00K | 134.00K | n/a |
| Stock-Based Compensation | 10.92M | 18.95M | 32.69M | 14.58M | 1.45M | n/a |
| Other Working Capital | 8.13M | -3.08M | 9.22M | 9.85M | -6.74M | -8.95M |
| Other Non-Cash Items | 3.82M | 3.77M | 10.07M | 1.26M | 952.00K | 2.73M |
| Deferred Income Tax | n/a | n/a | 2.78M | 633.00K | 9.14M | n/a |
| Change in Working Capital | 5.34M | -8.49M | 11.42M | 14.44M | -5.94M | -8.52M |
| Operating Cash Flow | -78.26M | -118.21M | -126.88M | -80.52M | -39.90M | -18.57M |
| Capital Expenditures | -146.00K | -5.27M | -25.64M | -1.65M | -1.69M | -2.54M |
| Acquisitions | n/a | 3.00M | 8.00M | 500.00K | n/a | n/a |
| Purchase of Investments | -129.43M | -157.84M | -202.55M | -266.06M | n/a | n/a |
| Sales Maturities Of Investments | 194.81M | 188.31M | 182.37M | 95.60M | n/a | n/a |
| Other Investing Acitivies | n/a | -3.00M | -8.00M | -500.00K | -500 | -2.52K |
| Investing Cash Flow | 65.24M | 25.20M | -45.81M | -172.11M | -1.69M | -2.54M |
| Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | n/a | -1.35M | -37.00K | 284.00K | 175.60M | 45.97M |
| Financial Cash Flow | 135.00K | -1.35K | 166.66K | 228.75M | 175.60M | 45.97M |
| Net Cash Flow | -12.89M | -94.36M | -6.04M | -23.87M | 134.01M | 24.86M |
| Free Cash Flow | -78.41M | -123.48M | -152.52M | -82.17M | -41.59M | -21.11M |